Home Stock

Stock Research: ALK-Abelló

Independent stock analysis through peer comparison: Get the 360° View as an objective basis for stock decision-making and explore the detailed ranks.

ALK-Abelló

CPH:ALK B DK0060027142
34
  • Value
    8
  • Growth
    56
  • Safety
    Safety
    92
  • Combined
    41
  • Sentiment
    30
  • 360° View
    360° View
    34
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

ALK-Abello A/S is a Denmark-based pharmaceutical company specializing in allergy treatment, prevention, and diagnosis. Its main businesses include allergy vaccines (tablet, sublingual, subcutaneous), emergency treatments for anaphylaxis, and allergy diagnostics products like skin-prick tests. The company operates worldwide through subsidiaries, production units, and distributors in countries such as Austria, Canada, France, Italy, the Netherlands, Poland, Spain, Switzerland, the United States, and China. In the last fiscal year, the company had 2753 employees, a market cap of $6128 millions, profits of $493 millions, and revenue of $769 millions.

more

ANALYSIS: With an Obermatt 360° View of 34 (better than 34% compared with alternatives), overall professional sentiment and financial characteristics for the stock ALK-Abelló are below the industry average. The 360° View is based on consolidating four consolidated indicators, with half of the metrics below and half above average for ALK-Abelló. The consolidated Growth Rank has a good rank of 56, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. This means that growth is higher than for 56% of competitors in the same industry. In addition, the consolidated Safety Rank has a safer rank of 92 which means that the company has a financing structure that is safer than 92% comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. But the consolidated Value Rank has a less desirable rank of 8 which means that the share price of ALK-Abelló is on the higher side compared with typical size in indicators such as revenues, profits, and invested capital. This means that the stock price is higher than for 92% of alternative stocks in the same industry. The consolidated Sentiment Rank also has a low rank of 30, which means that professional investors are more pessimistic about the stock than for 70% of alternative investment opportunities. ...read more

more
Strongest Rank Market Pulse
Weakest Rank Liquidity
Country Denmark
Industry Pharmaceuticals
Size Medium
Website alk.net
Index
ALK-Abelló stock price by TradingView. Not sourced by Obermatt.
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 3-Sep-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Value
Identifies how good a value the stock is.
Good Value Expensive
Combined
Consolidated view across Value, Growth, and Safety.
Good Tread Carefully
Growth
Shows a company's growth potential.
High Growth Tough Times
Sentiment
Shows what the market thinks of a stock.
Positive Sentiment Skepticism
Safety
Safety
Assesses how financially secure a company is.
Well-Financed High Leverage
360° View
360° View
Holistic stock analysis: all key non-/financial metrics
Good Watch Out

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for more than 8,000 stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
8 1 5 1
Growth
56 86 63 77
Safety
Safety
92 73 64 27
Sentiment
30 70 56 58
360° View
360° View
34 81 41 30
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for more than 8,000 stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
75 80 72 55
Opinions Change
50 6 17 50
Pro Holdings
n/a 55 34 30
Market Pulse
6 87 91 79
Sentiment
30 70 56 58
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for more than 8,000 stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
8 1 5 1
Growth
56 86 63 77
Safety Safety
92 73 64 27
Combined
41 73 32 15
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for more than 8,000 stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
26 7 22 15
Price vs. Earnings (P/E)
7 9 12 3
Price vs. Book (P/B)
14 1 14 3
Dividend Yield
50 1 1 1
Value
8 1 5 1
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for more than 8,000 stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
86 87 67 65
Profit Growth
52 74 86 96
Capital Growth
42 76 10 11
Stock Returns
43 61 56 72
Growth
56 86 63 77
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for more than 8,000 stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
78 67 70 51
Refinancing
62 25 33 26
Liquidity
94 90 62 34
Safety Safety
92 73 64 27

Similar Stocks

Discover high‑ranked alternatives to ALK-Abelló and broaden your portfolio horizons.

Fresenius

GER:FRE
Country: Germany
Industry: Health Care Services
Size: X-Large
Full Stock Analysis

Henkel

GER:HEN3
Country: Germany
Industry: Household Products
Size: X-Large
Full Stock Analysis

Faes Farma

MCE:FAE
Country: Spain
Industry: Pharmaceuticals
Size: Medium
Full Stock Analysis

Strabag

VIE:STR
Country: Austria
Industry: Construction & Engineering
Size: X-Large
Full Stock Analysis

Frequently Asked
Questions

The company has high growth and safe financing but is expensive (low Value Rank) and has low market sentiment. This is a warning that the stock may be too expensive. This is for an experienced growth investor willing to risk overpaying, but only after conducting thorough research on future growth potential.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

OTHER FEATURES

Use the Platform to its Fullest

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing:

Review us See More Google Reviews